BOL-303242-X Ophthalmic Suspension

· Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BOL-303242-X Ophthalmic Suspension, covering 2020-09-03 to 2020-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome [Phase 2]